title: Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis.
abstract: Objectives. Otomycosis is a common ENT disease frequenting the tropics. Its recurrent nature poses a great challenge to the treating physician. In spite of a number of antifungals in the market, the frequent nature of this disease warrants repeated use of these drugs, contributing to drug resistance and financial burden on the rural population. Our primary aims were to evaluate the effectiveness of povidone iodine in the treatment of otomycosis and to identify the most common fungal isolate in our population. Study Design and Setting. A single blinded prospective longitudinal study was done over a period of 12 months in a tertiary referral center. 34 patients in the age group 15-70 years clinically diagnosed with otomycosis were included in this study. These individuals were divided into two groups selected randomly. One arm received 7.5% povidone iodine otic drops and the other 1% Clotrimazole and lignocaine drops. Evaluation was based on resolution of symptoms and signs after treatment. Result. Both arms showed improvements which were comparable thus suggesting the role of povidone iodine in the management of otomycosis. Conclusion. Povidone iodine is an effective antifungal in the treatment of otomycosis.
authors: Department of ENT Unit-1, Christian Medical College, Indian Subcontinent, Vellore 632004, India.
authors: Ajay
authors: A
authors: Philip
authors: Regi
authors: R
authors: Thomas
authors: Anand
authors: A
authors: Job
authors: V Rajan
authors: VR
authors: Sundaresan
authors: Shalini
authors: S
authors: Anandan
authors: Rita Ruby
authors: RR
authors: Albert
references: Emerg Infect Dis. 2004 Jan;10(1):14-9
references: 15078591
references: Int J Pediatr Otorhinolaryngol. 2008 Apr;72(4):453-9
references: 18279975
references: Ear Nose Throat J. 2000 Aug;79(8):606-9
references: 10969470
references: Kansenshogaku Zasshi. 2011 Jul;85(4):333-9
references: 21861435
references: Mycoses. 2012 Sep;55(5):404-9
references: 21999222
references: J Laryngol Otol. 1990 May;104(5):387-9
references: 2370463
references: PLoS Pathog. 2011 Sep;7(9):e1002257
references: 21931556
references: J Antimicrob Chemother. 2007 Aug;60(2):417-20
references: 17586808
references: Acta Otorrinolaringol Esp. 2005 May;56(5):181-6
references: 15960119
references: Calif Med. 1948 May;68(5):359-61
references: 18731443
references: Arch Otolaryngol. 1946 Mar;43:213-25
references: 21023138
references: J Laryngol Otol. 2003 Jan;117(1):39-42
references: 12590854
references: J Laryngol Otol. 1978 Oct;92(10):869-76
references: 712219
references: Arch Otolaryngol Head Neck Surg. 2003 Oct;129(10):1098-100
references: 14568795
references: J Laryngol Otol. 1961 Jan;75:45-69
references: 13708423
references: J Laryngol Otol. 1962 Sep;76:713-9
references: 13956921
references: Otolaryngol Head Neck Surg. 2006 Nov;135(5):787-91
references: 17071313